<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8CB3A3FE-C4A8-42E9-9244-671C2BC53767"><gtr:id>8CB3A3FE-C4A8-42E9-9244-671C2BC53767</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>T</gtr:otherNames><gtr:surname>Walton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081977"><gtr:id>9F63B486-E44B-4CC3-B0B4-9149FB372891</gtr:id><gtr:title>Investigation of effects of inactive CYP2C19 alleles in chlorproguanil pharmacokinetics in adults</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081977</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>No abstract available</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>215943</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Gambia Schools Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>560CE006-CEE0-490A-AAF9-664A3FA760CA</gtr:id><gtr:impact>F S-J was main person presenting our work with that of the rest of the MRC Gambia - well attended by local schools.

Increased knowledge of the work of the MRC Gambia and thus potential for recruitment of local school leavers.</gtr:impact><gtr:outcomeId>cmtg6k5uULb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Gambia Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7ABF7492-4B38-4D22-87C9-9FCB971C26DC</gtr:id><gtr:impact>Visitors discussed research over posters and demonstrations at the MRC Gambia.

Increase knowledge locally of the work of the MRC and thus potential for dissemination of outputs locally and trial recruitment,</gtr:impact><gtr:outcomeId>ogSCzDatafC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR/MRC/EME Parent determined oral montelukast therapy for preschool wheeze. Co Applicant</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>93594917-773A-47FF-8256-02FCC133CC3A</gtr:id><gtr:outcomeId>bHeZgAPQBQF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP PhD Studentship Ramatoullie Janha</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>52D75C5D-A965-41C6-A4E1-8C2BF4522D70</gtr:id><gtr:outcomeId>Hv5z7oKUTEe0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP PhD Studentship Louis-Marie Yindom</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>D22B9EC9-A5BB-450E-800D-88B2F60056E0</gtr:id><gtr:outcomeId>nbu5e8ywQja0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Centre for Applied Research. &amp;pound;2,000,000. Programme 2: How do we help people with asthma to treat and manage their symptoms, and maximise the benefits they get from treatment?</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>333E14DE-7B80-4ECD-8DB5-1A49BDF28FE7</gtr:id><gtr:outcomeId>Yo6vLqpGohC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99278</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE PhD Studentship Alistair Brock</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1B6694F1-5799-487D-9BAF-081700DD9245</gtr:id><gtr:outcomeId>DyBnYWasQxS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Optimising pharmacist-based treatment for smoking cessation. Principal Investigator.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C076D6C2-9CEA-4BC2-98A1-E9AA0FE099C5</gtr:id><gtr:outcomeId>jDwLhu8Cyhn0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1671212</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Health Technology Assessment Programme (HTA)</gtr:department><gtr:description>e-cigaretes for smoking cessation in pregnancy- a randomised controlled trial</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0FE161B5-3CBC-4F98-B6B5-5757FB3DC0A9</gtr:id><gtr:outcomeId>58c79796ac4480.20483443</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Paper cited by five clinically orientated reviews in West African and international yournals</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2724D57E-7CFE-45F7-A695-12E991758FB0</gtr:id><gtr:impact>Potential impact on design of trials for antimalarial compounds to take into account pharmacogenetic variations</gtr:impact><gtr:outcomeId>GhXtFBqyQp4</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>e-cigaretes for smoking cessation in pregnancy - HTA funded trial starting 2017</gtr:description><gtr:id>1A20D88C-50EA-493E-A468-945D843A30CB</gtr:id><gtr:impact>Pending results of trial</gtr:impact><gtr:outcomeId>58c799320ffd72.09087969</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>e-cigaretes for smoking cessation in pregnancy</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Detailed pharmacokinetic data on chlorproguanil and dapsone and DNA samples on 43 adult Gambians with ethical approval for analysis. Typed for 20 key markers in the CYP2C19/C9 gene cluster - suitable for whole genome analysis/ exome sequencing to identify novel variants and developing new diagnostic assays.</gtr:description><gtr:id>B07D2FA6-A16D-485C-A815-9614CACF0EF6</gtr:id><gtr:impact>Paper in progress describing effects on treatment of malaria in Gambian children.</gtr:impact><gtr:outcomeId>YmHfYnGbHvp</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CYP2C19/C9 Pharmacogenetic database</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Key genetic determinants of levels of drugs metabolised by these enzymes have been described and the omptimised panel would be available for use in randomised controlled trials of antimalarials or other drugs metabolised by these enzymes.</gtr:description><gtr:id>F8DD4029-825F-46A3-949F-D48A21A67D5E</gtr:id><gtr:impact>Used in clinical study of antimalarial treatment in Gambian children.</gtr:impact><gtr:outcomeId>bd71Ydq5Lje</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CYP2C19/C9 SNP panel for studies of antimalarial drugs in Africans</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>86B4FB1E-5C28-4E53-9C79-DDA089F7E95C</gtr:id><gtr:title>KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa9511ec47ca7.81477763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A098452E-1FD0-4233-B2BF-6503093B583E</gtr:id><gtr:title>The role of zebrafish (Danio rerio) in dissecting the genetics and neural circuits of executive function.</gtr:title><gtr:parentPublicationTitle>Frontiers in neural circuits</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6a03494836c3a0d9c18193adc7b1aa1"><gtr:id>c6a03494836c3a0d9c18193adc7b1aa1</gtr:id><gtr:otherNames>Parker MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1662-5110</gtr:issn><gtr:outcomeId>pm_16595_25_23580329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFF54ED3-0212-4BA7-96F9-D3F2695BF1DF</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>Akn8n5HUYNK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A340AF27-E438-4352-9D0C-98CF07C92C9C</gtr:id><gtr:title>Population genetic analyses of Helicobacter pylori isolates from Gambian adults and children.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9e6e30430ff7ff66b11c1a75d8cab2f"><gtr:id>d9e6e30430ff7ff66b11c1a75d8cab2f</gtr:id><gtr:otherNames>Secka O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>548581c970f466.54878309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A4D74F-C74E-419B-9C3B-DF644FCD714B</gtr:id><gtr:title>Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bff4ee4ff81e130304b8d75404a55387"><gtr:id>bff4ee4ff81e130304b8d75404a55387</gtr:id><gtr:otherNames>Yindom LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>Qkc4j5XubuN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A37F3D-8827-4C47-A836-16EF98BD2F90</gtr:id><gtr:title>Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e153d31b0ad14e6f7f06a2a5603f548f"><gtr:id>e153d31b0ad14e6f7f06a2a5603f548f</gtr:id><gtr:otherNames>Jolliffe DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>56e18597baf7f0.20609606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>114C7210-1059-4CEE-9F18-7F3B79C87FE8</gtr:id><gtr:title>Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e153d31b0ad14e6f7f06a2a5603f548f"><gtr:id>e153d31b0ad14e6f7f06a2a5603f548f</gtr:id><gtr:otherNames>Jolliffe DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>5aa9520ea659b6.67755460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91FB0D24-835F-463C-858D-3C075E757B46</gtr:id><gtr:title>Need to test impact of DNA-based risk scores</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f70975d8fed912eea789a8806c0f2a38"><gtr:id>f70975d8fed912eea789a8806c0f2a38</gtr:id><gtr:otherNames>Griffiths C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56e1877c2efd07.77990936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>186E183F-DB5A-43FA-AD12-48677E5A8818</gtr:id><gtr:title>Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24fc3676f2763bc84d919cbba0f70c68"><gtr:id>24fc3676f2763bc84d919cbba0f70c68</gtr:id><gtr:otherNames>Dunyo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>cn6WC3dnkq6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89CF412D-DC7A-4EC7-BD26-C5BFCDA7D9A6</gtr:id><gtr:title>Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7193c9cd0ef4437dff54c28576fbce01"><gtr:id>7193c9cd0ef4437dff54c28576fbce01</gtr:id><gtr:otherNames>Walton R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>QeNDsMpkZWd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BADA30D-6779-4022-8F00-E0561FABAEDB</gtr:id><gtr:title>Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs).</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc8267178fe5eccc89abeb20ec15544"><gtr:id>0dc8267178fe5eccc89abeb20ec15544</gtr:id><gtr:otherNames>Martineau AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>56e18565285404.38277677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E77E236-B2D3-4400-BA8F-3C9BB502AFB0</gtr:id><gtr:title>Estimation of Saliva Cotinine Cut-Off Points for Active and Passive Smoking during Pregnancy-Polish Mother and Child Cohort (REPRO_PL).</gtr:title><gtr:parentPublicationTitle>International journal of environmental research and public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7465b061a8899f5be8d5ed57bc762e00"><gtr:id>7465b061a8899f5be8d5ed57bc762e00</gtr:id><gtr:otherNames>Polanska K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1660-4601</gtr:issn><gtr:outcomeId>5aa9539657c642.21082128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5698E7F9-A1E3-49D5-8445-8A50404820C4</gtr:id><gtr:title>Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.</gtr:title><gtr:parentPublicationTitle>Pharmacogenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cda09f35d3ba99fe9f6c814453a7d0d"><gtr:id>6cda09f35d3ba99fe9f6c814453a7d0d</gtr:id><gtr:otherNames>Janha RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1462-2416</gtr:issn><gtr:outcomeId>GyTU7Kg56gw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A18491AE-79BF-47F3-9C7C-F85F22619544</gtr:id><gtr:title>Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cda09f35d3ba99fe9f6c814453a7d0d"><gtr:id>6cda09f35d3ba99fe9f6c814453a7d0d</gtr:id><gtr:otherNames>Janha RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>548583bde7eeb5.58134326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED9DAB60-E9BC-421E-9DCB-C82FE4694F6D</gtr:id><gtr:title>HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9220bd722f843e0dac27ddc9068ac50c"><gtr:id>9220bd722f843e0dac27ddc9068ac50c</gtr:id><gtr:otherNames>Walther M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16595_25_22438807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>434BBE72-7453-4AD0-B089-38440EBEC332</gtr:id><gtr:title>Hepatitis B Virus Infection as a Neglected Tropical Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d16cccce5e895a02e1d0e5c45995946a"><gtr:id>d16cccce5e895a02e1d0e5c45995946a</gtr:id><gtr:otherNames>O'Hara G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa95523df6b38.39207552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B04555E-434C-4BB9-A464-2BFD291708DB</gtr:id><gtr:title>Environmental and genetic determinants of vitamin D status among older adults in London, UK.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e153d31b0ad14e6f7f06a2a5603f548f"><gtr:id>e153d31b0ad14e6f7f06a2a5603f548f</gtr:id><gtr:otherNames>Jolliffe DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>58c793c54ff980.24727589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AA2CDF2-7004-4BDC-A93C-A23C84CBA91C</gtr:id><gtr:title>Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e153d31b0ad14e6f7f06a2a5603f548f"><gtr:id>e153d31b0ad14e6f7f06a2a5603f548f</gtr:id><gtr:otherNames>Jolliffe DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>5aa950cf839814.18170100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>447C7024-F6F2-469F-BB37-F9BB111C5907</gtr:id><gtr:title>Maternal genotype and severe preeclampsia: a HuGE review.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4187b0651510bc9cad7fd1529a39a4a2"><gtr:id>4187b0651510bc9cad7fd1529a39a4a2</gtr:id><gtr:otherNames>Fong FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>548583733c0922.07777449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B63C188-2949-40AC-A9F0-EB658BE886FD</gtr:id><gtr:title>DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/626748277705ea30580bc3e5380c0b58"><gtr:id>626748277705ea30580bc3e5380c0b58</gtr:id><gtr:otherNames>Kuan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>doi_16595_148_13_144</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081977</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>